Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

USTekinumab in Fistulising Perianal Crohn's Disease (CD): The USTAP CD Study

NCT04496063 is registered in ClinicalTrials.gov with Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives as lead sponsor.

NCT NCT04496063
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04496063 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
USTekinumab in Fistulising Perianal Crohn's Disease (CD): The USTAP CD Study
Lead sponsor
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
Phase
Phase 4
Overall status
Unknown status
Start date
November 16, 2020
Completion date
December 30, 2025
Enrollment
33 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease